The Lancet HIV in conversation with
Celková doba trvání:
14 h 08 min
Debra ten Brink and Rowan Martin-Hughes on the effects of international aid cuts on HIV acquisitions and mortality
The Lancet HIV in conversation with
24:00
Sari Reisner on the benefits of gender-affirming hormone therapy on HIV clinical outcomes
The Lancet HIV in conversation with
21:28
Lisa Noguchi and Nyaradzo Mgodi on HIV prophylactic dapivirine ring in breastfeeding women
The Lancet HIV in conversation with
23:02
Sharon Lewin on requirements of a cell- and gene-based therapy product for HIV cure
The Lancet HIV in conversation with
23:55
Claudia Cortes y Giovanni Ravasi sobre VIH y migración (in Spanish)
The Lancet HIV in conversation with
33:29
Florence Riako Anam and Bruce Richman on U=U
The Lancet HIV in conversation with
24:50
Peter Hayward on 10 years of The Lancet HIV
The Lancet HIV in conversation with
22:18
Salome Kuchukidze and Souleymane Diabaté on the link between intimate partner violence and vertical HIV transmission in sub-Saharan Africa
The Lancet HIV in conversation with
23:15
José M. Zuniga on the future of urban HIV responses Commission
The Lancet HIV in conversation with
21:43
Alejandro García sobre los tiempos de transición en la atención médica continuada del VIH en España (ES)
The Lancet HIV in conversation with
24:37
Serge Eholie on treatments for HIV-2
The Lancet HIV in conversation with
25:42
Drew Voetsch and Robert Selato on achieving the 95-95-95 UNAIDS goals in Botswana
The Lancet HIV in conversation with
21:09
Adam Trickey on trends in causes of death among people with HIV in Europe and North America
The Lancet HIV in conversation with
10:54
Manik Kohli, Iain Reeves, and Laura Waters on homophobia in the provision of sexual health care in the UK
The Lancet HIV in conversation with
40:47
Lulu Nair, Connie Celum, and Kenneth Ngure on dapivirine vaginal ring and daily oral PrEP for HIV prevention in women
The Lancet HIV in conversation with
14:04
Sophia Rein on HIV treatment with INSTIs and cardiovascular events
The Lancet HIV in conversation with
14:11
Lawrence Mbuagbaw on reporting of HIV drug resistance in clinical studies using the CEDRIC-HIV checklist
The Lancet HIV in conversation with
08:20
Andreas Jahn and Nellie Wadonda-Kabondo on trends in HIV prevalence and incidence
The Lancet HIV in conversation with
23:10
Eryn Braley and Mckenzie Braley on experiences of HIV among global Indigenous populations
The Lancet HIV in conversation with
20:16
Ricardo Luque and Miguel Barriga on HIV prevalence and care continuum among migrants from Venezuela in Colombia (en Español)
The Lancet HIV in conversation with
44:04
Denton Callander on the effects of treatment as prevention
The Lancet HIV in conversation with
17:55
Andrea Wirtz and Sari Reisner on HIV incidence and mortality among transgender women
The Lancet HIV in conversation with
25:02
Yasmin Mohamed on early infant diagnosis of HIV
The Lancet HIV in conversation with
16:21
Salome Kuchukhidze and Francisco Mbofana on intimate partner violence and women with HIV
The Lancet HIV in conversation with
21:43
Lise Jamieson and Gesine Mayer-Rath on cabotegravir for PrEP in South Africa
The Lancet HIV in conversation with
25:00
Helen Ayles and Musonda Simwinge on the PopART trial
The Lancet HIV in conversation with
28:29
Carol Strong and Stephane Ku on HIV and chemsex
The Lancet HIV in conversation with
16:41
Elijah Kakande and Gabriel Chamie on TB interventions for people with HIV
The Lancet HIV in conversation with
20:17
Amir Mohareb on PrEP and hepatitis B
The Lancet HIV in conversation with
12:09
Kenneth Ngure on PrEP in Kenya
The Lancet HIV in conversation with
12:00
Marta Vasylyev and Casper Rokx on HIV care for displaced Ukranians
The Lancet HIV in conversation with
21:14
Angela Colbers and Hylke Waalewijn on treatment for children with HIV
The Lancet HIV in conversation with
19:46
Nabila El-Bassel on intimate partner violence and HIV
The Lancet HIV in conversation with
14:46
Amy Justice on ageing with HIV
The Lancet HIV in conversation with
14:01
Bridget Mugisa on the epidemiology of HIV in the Middle East and north Africa
The Lancet HIV in conversation with
13:49
Aaloke Mody and Izukanji Sikazwe on universal HIV treatment in Zambia
The Lancet HIV in conversation with
20:59
José Miro and Juliana Reyes on COVID-19 in people living with HIV
The Lancet HIV in conversation with
26:42
Jon Shuter on smokers with HIV
The Lancet HIV in conversation with
23:56
Elizabeth Marie King on menopausal hormone therapy
The Lancet HIV in conversation with
13:34
John Frater on COVID-19 vaccination and HIV
The Lancet HIV in conversation with
18:52
